<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/ntla" ></link>
<id>urn:uuid:016feaa3-be57-0d21-ad9f-0a1a1701701a</id>
<updated>2026-05-01T17:11:50-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>NTLA: LEONARD JOHN M (PR,CEO,DIR) Acquired (JB) 156,400 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6347030" ></link>
<id>urn:uuid:bce63307-6e02-481c-19b2-934acd06da83</id>
<updated>2026-03-03T16:19:05-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: BASTA JAMES (VP,GC) Sold (S) 1,211 Shares of INTELLIA THERAPEUTICS INC for $13.78 on 3/2</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6350356" ></link>
<id>urn:uuid:a6984a5f-2267-293c-05a9-a3196d76cf7c</id>
<updated>2026-03-03T16:18:31-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: BASTA JAMES (VP,GC) Acquired (JB) 46,080 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6350355" ></link>
<id>urn:uuid:ee54a9d4-37e3-b4a5-ff4e-028857d6db62</id>
<updated>2026-03-03T16:18:31-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: LEBWOHL DAVID (VP) Acquired (JB) 9,943 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6346965" ></link>
<id>urn:uuid:fb1f8078-3b55-5352-414c-0e1dc0c5a939</id>
<updated>2026-03-03T16:18:01-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: DULAC EDWARD J III (VP,CFO) Acquired (JB) 61,280 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6346979" ></link>
<id>urn:uuid:658d93df-5b74-180a-8e14-f96438c9e188</id>
<updated>2026-03-03T16:17:34-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: SCHULTES BIRGIT C (VP) Acquired (JB) 39,200 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6346987" ></link>
<id>urn:uuid:5898b9d5-c272-cd04-5682-2b2dce9514b3</id>
<updated>2026-03-03T16:17:09-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: CLARK ELIANA (VP,CTO) Acquired (JB) 7,353 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6347008" ></link>
<id>urn:uuid:0fb90f30-f333-199b-ee30-74f207e24268</id>
<updated>2026-03-03T16:16:13-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: CLARK ELIANA (VP,CTO) Sold (S) 607 Shares of INTELLIA THERAPEUTICS INC for $13.78 on 3/2</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6347009" ></link>
<id>urn:uuid:0ffa411c-a49f-86c5-34c6-fc0a6edcdbfe</id>
<updated>2026-03-03T16:16:13-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: DUBE MICHAEL P (VP,CAO) Acquired (JB) 17,250 Shares of INTELLIA THERAPEUTICS INC for $0.00 on 3/1</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6350442" ></link>
<id>urn:uuid:3ba654aa-83fd-437f-8c40-c01844bca628</id>
<updated>2026-03-03T16:15:37-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
<entry>
<title>NTLA: LEONARD JOHN M (PR,CEO,DIR) Sold (S) 34,146 Shares of INTELLIA THERAPEUTICS INC for $9.21 on 1/5</title>
<link href="http://www.insiderinsights.com/company/ntla/intellia-therapeutics-inc/id-6304976" ></link>
<id>urn:uuid:8421110a-eee6-b38a-cfe0-deb6587bc9a9</id>
<updated>2026-01-07T16:05:54-05:00</updated>
<summary type="html" ><![CDATA[INTELLIA THERAPEUTICS INC (NTLA). Recent Price: $13.89. Mkt Cap:1.7B. 10D Vol: 10.1mm]]></summary>
</entry>
</feed>